E2 ModeratePreliminaryPEM ✗Cross-SectionalPeer-reviewedMachine draft
Standard · 3 min

Characterizing Sjögren-Associated Fatigue: A Distinct Phenotype from ME/CFS.

Kim, Laura, Kedor, Claudia, Buttgereit, Frank et al. · Journal of clinical medicine · 2023 · DOI

Quick Summary

This study compared fatigue in people with Sjögren's syndrome (an autoimmune disease affecting moisture-producing glands) to fatigue in ME/CFS patients. While both groups experience severe tiredness, the researchers found important differences: Sjögren's patients recovered their muscle strength within an hour of activity, whereas ME/CFS patients typically experience worsening symptoms hours after exertion. Only a small portion of Sjögren's patients met ME/CFS diagnostic criteria, suggesting these are distinct conditions despite some symptom overlap.

Why It Matters

This study helps clarify that severe fatigue in Sjögren's syndrome represents a distinct phenotype from ME/CFS, which is clinically important for accurate diagnosis and treatment planning. The finding that post-exertional malaise in Sjögren's differs fundamentally from ME/CFS (emotional vs. physical trigger, rapid vs. delayed recovery) helps researchers and clinicians distinguish between these conditions and may inform mechanistic understanding of ME/CFS pathophysiology.

Observed Findings

  • Only 4 of 18 pSS patients (22%) met ME/CFS diagnostic criteria using the Canadian Consensus Criteria.
  • In pSS, hand grip strength fully recovered within one hour after exertion, unlike the prolonged post-exertional malaise typical of ME/CFS.
  • Post-exertional malaise in pSS patients was primarily triggered by mental/emotional exertion rather than physical exertion.
  • Hand grip strength correlated significantly with fatigue severity in pSS patients (p < 0.05).
  • β1-, β2-, and M4-receptor autoantibodies correlated with overall disease activity but not specifically with fatigue severity.

Inferred Conclusions

  • Fatigue in primary Sjögren's syndrome represents a phenotypically distinct condition from ME/CFS despite both involving severe fatigue and exertional intolerance.
  • Post-exertional malaise in pSS differs fundamentally from ME/CFS in both trigger type (emotional vs. physical) and recovery pattern (rapid vs. prolonged).
  • Hand grip strength is an objective, clinically useful measure for assessing overall fatigue severity in pSS.
  • Autoimmune mechanisms in pSS-associated fatigue may differ from those in ME/CFS.

Remaining Questions

  • What mechanisms drive the distinct phenotypes of fatigue in pSS versus ME/CFS, and are there shared immune or neurological pathways?
  • Why does emotional exertion trigger post-exertional malaise in pSS while physical exertion typically does so in ME/CFS?
  • Could a larger, longitudinal study identify additional subgroups of pSS patients with ME/CFS-like features and characterize their clinical trajectory?
  • What role do the identified autoantibodies (β1-, β2-, M4-receptors) play in Sjögren's-related fatigue, and are equivalent autoantibodies present in ME/CFS?

What This Study Does Not Prove

This small cross-sectional study cannot establish causation or determine why these conditions differ mechanistically. The study does not prove that autoantibodies are unrelated to fatigue in ME/CFS, only that they correlate differently in pSS. It also cannot rule out that a subset of patients have overlapping pSS and ME/CFS rather than distinct conditions.

Topics

Tags

Symptom:Post-Exertional MalaiseUnrefreshing SleepPainFatigue
Biomarker:AutoantibodiesBlood Biomarker
Method Flag:No ControlsSmall SampleStrong Phenotyping

Metadata

DOI
10.3390/jcm12154994
PMID
37568396
Review status
Machine draft
Evidence level
Single-study or moderate support from human research
Last updated
7 April 2026